Your browser doesn't support javascript.
loading
A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma.
Macias, Rocio I R; Muñoz-Bellvís, Luis; Sánchez-Martín, Anabel; Arretxe, Enara; Martínez-Arranz, Ibon; Lapitz, Ainhoa; Gutiérrez, M Laura; La Casta, Adelaida; Alonso, Cristina; González, Luis M; Avila, Matias A; Martinez-Chantar, Maria L; Castro, Rui E; Bujanda, Luis; Banales, Jesus M; Marin, Jose J G.
Afiliação
  • Macias RIR; Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, Biomedical Research Institute of Salamanca (IBSAL), 37007 Salamanca, Spain.
  • Muñoz-Bellvís L; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), 28029 Madrid, Spain.
  • Sánchez-Martín A; Service of General and Gastrointestinal Surgery, University Hospital of Salamanca, IBSAL, CIBERONC, 37007 Salamanca, Spain.
  • Arretxe E; Experimental Hepatology and Drug Targeting (HEVEFARM) Group, University of Salamanca, Biomedical Research Institute of Salamanca (IBSAL), 37007 Salamanca, Spain.
  • Martínez-Arranz I; OWL Metabolomics, Bizkaia Technology Park, 48160 Derio, Spain.
  • Lapitz A; OWL Metabolomics, Bizkaia Technology Park, 48160 Derio, Spain.
  • Gutiérrez ML; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), 20014 San Sebastian, Spain.
  • La Casta A; Department of Medicine and Cytometry Service (NUCLEUS), University of Salamanca, Cancer Research Center (IBMCC-CSIC/USAL), IBSAL, CIBERONC, 37007 Salamanca, Spain.
  • Alonso C; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), 20014 San Sebastian, Spain.
  • González LM; OWL Metabolomics, Bizkaia Technology Park, 48160 Derio, Spain.
  • Avila MA; Service of General and Gastrointestinal Surgery, University Hospital of Salamanca, IBSAL, CIBERONC, 37007 Salamanca, Spain.
  • Martinez-Chantar ML; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), 28029 Madrid, Spain.
  • Castro RE; Program of Hepatology, Center for Applied Medical Research (CIMA), University of Navarra-IDISNA, 31008 Pamplona, Spain.
  • Bujanda L; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), 28029 Madrid, Spain.
  • Banales JM; Liver Disease Lab Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, 48160 Derio, Spain.
  • Marin JJG; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.
Cancers (Basel) ; 12(6)2020 May 31.
Article em En | MEDLINE | ID: mdl-32486461
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha